Archives of “Adverse effect” tag

rss

AstraZeneca Covid-19 vaccine – study put on hold due to suspected adverse reaction in trial participant

  
  Analysis
#  #  #  #  #  #  #  #  #  #

The Phase 3 study testing the AstraZeneca and the University of Oxford COVID-19 vaccine has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom.

Spokesperson for AstraZeneca
  • standard review process triggered a pause to vaccination to allow review of safety data
  • “a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”
Risk negative, but so far little response. Eyes on the tech rout still. Globex equity index future trade reopens at the top of this hour.
coronavirus

Fauci says its likely there will be tens of million of vaccine doses by the end of this year

  
  Analysis
#  #  #  #  #  #  #  #  #  #

US infectious diseases expert Fauci speaking in an interview with Reuters

Expects a safe and effective vaccine will have received approval by the end of 2020
  • says there is a middle ground where the country can prudently open amid the coronavirus
  • says some sections of the country have done well but other parts are on fire
  • says he does expect a safe and effective vaccine to receive approval by year end
  • says manufacturers say a billion doses of vaccine will be available by the end of 2021
  • we will likely have tens of millions of doses of vaccine by the end of this year
  • he would be satisfied by a trial that included thousands of people and showed no signs of unexpected severe adverse events
  • he has not seen any indication of pressure from white house on vaccine
  •  says regulatory authorities have promised that safety and efficacy of vaccine will be paramount concern

US infectious diseases expert Fauci speaking in an interview with Reuters 

Pfizer/BionTech announce positive vaccine study results

  
  Analysis
#  #  #  #  #  #  #

Update from German Phase 1 and Phase 2 studies

Pfizer/BionTech have announced positive vaccine study results for their German phase I and phase II studies.
According to the companies the results showed a strong t-cell . The results expands upon early results from their US trial. There were no serious adverse events reported.
Go to top